Knoop, R. F., Sparn, M., Waldmann, J., Plassmeier, L., Bartsch, D. K., Lauth, M., . . . Fendrich, V. (2014). Chronic Pancreatitis and Systemic Inflammatory Response Syndrome Prevent Impact of Chemotherapy with Gemcitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer()(). Neoplasia Press.

Knoop, Richard F., Moritz Sparn, Jens Waldmann, Lars Plassmeier, Detlef K. Bartsch, Matthias Lauth, Christoph Hudemann, and Volker Fendrich. Chronic Pancreatitis and Systemic Inflammatory Response Syndrome Prevent Impact of Chemotherapy With Gemcitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer()(). Neoplasia Press, 2014.

Knoop, Richard F., et al. Chronic Pancreatitis and Systemic Inflammatory Response Syndrome Prevent Impact of Chemotherapy With Gemcitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer()(). Neoplasia Press, 2014.